SOCS3 targets Siglec 7 for proteasomal degradation and blocks Siglec 7-mediated responses |
| |
Authors: | Orr Selinda J Morgan Nuala M Buick Richard J Boyd Caroline R Elliott Joanne Burrows James F Jefferies Caroline A Crocker Paul R Johnston James A |
| |
Affiliation: | Division of Infection and Immunity, Centre for Cancer Research and Cell Biology, Queens University, 97 Lisburn Road, Belfast BT9 7BL, United Kingdom. |
| |
Abstract: | CD33-related Siglecs (sialic acid-binding immunoglobulin-like lectins) 5-11 are inhibitory receptors that contain a membrane proximal ITIM (immunoreceptor tyrosine-based inhibitory motif) (I/V/L/)XYXX(L/V), which can recruit SHP-1/2. However, little is known about the regulation of these receptors. SOCS3 (suppressor of cytokine signaling 3) is up-regulated during inflammation and competes with SHP-1/2 for binding to ITIM-like motifs on various cytokine receptors resulting in inhibition of signaling. We show that SOCS3 binds the phosphorylated ITIM of Siglec 7 and targets it for proteasomal-mediated degradation, suggesting that Siglec 7 is a novel SOCS target. Following ligation, the ECS E3 ligase is recruited by SOCS3 to target Siglec 7 for proteasomal degradation, and SOCS3 expression is decreased concomitantly. In addition, we found that SOCS3 expression blocks Siglec 7-mediated inhibition of cytokine-induced proliferation. This is the first time that a SOCS target has been reported to degrade simultaneously with the SOCS protein and that inhibitory receptors have been shown to be degraded in this way. This may be a mechanism by which the inflammatory response is potentiated during infection. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|